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1. Introduction 
While the heat-stable protein inhibitor (PKI) of the 
CAMP-dependent protein kinase was first described in 
skeletal muscle [I] from which it was recently isolated 
in pure form [2] , its greatest concentration occurs in 
the brain [3] . This is not surprising in view of the 
very high concentration of protein kinase found in 
this tissue [4] . It has recently been proposed that 
CAMP-dependent phosphorylations might be involved 
in neuronal functions, such as tissue growth, mem- 
brane permeability and synaptic transmission (reviewed 
[S-7] ). Another protein kinease inhibitor has also 
been described in nervous tissue that can block phos- 
phorylations catalyzed by both cyclic nucleotide- 
dependent and -independent enzymes [8]. 
It thus appeared desirable to reinvestigate the 
protein kinase system of the brain. As a first step 
towards this goal, beef brain protein kinase inhibitor 
was purified by the procedure established for isola- 
tion of the skeletal muscle protein [2] ; some of its 
properties were also investigated. 
Abbreviations: PKI, protein kinase inhibitor; CAMP, cyclic 
adenosine 3’:5’-monophosphate; cCMP, cyclic guanosine 
3’:S’monophosphate; C, catalytic subunit; Tris, tris(hydroxy- 
methyl)amino methane 
Enzymes: protein kinase, ATP:protein phosphotransferase 
(EC 2.7.1.37) 
+ On leave of absence from the Medical School, University of 
Montpellier I; to whom correspondence and reprint requests 
should be addressed. Present address: Centre de Recherches 
de Biochimie Macromoleculaire, CNRS, BP 5051, 34033 
Montpellier Cedex, France 
ElsevierjNorth-Holland Biomedical Press 
2. Materials and methods 
Histone HA and protein markers were obtained 
from Sigma and 32P from New England Nuclear; 
[-y-32P] ATP, ca. 780 mCi/mmol, was prepared by the 
procedure in [9]. The catalytic subunit of the CAMP- 
dependent protein kinase was isolated from bovine 
heart and assayed as in [2,10] ; the protein kinase 
inhibitor from rabbit skeletal muscle and bovine brain 
were also assayed as in [2]. The cGMP-dependent 
protein kinase was purified from fresh bovine lung up 
to the affinity step and assayed as in [ 1 I] . Affinity 
chromatography was carried out on a CAMP-Sepharose 
6B column as in [ 121 . 
Protein concentration was determined as in [ 131. 
Molecular weight was estimated by electrophoresis 
in 0.1% dodecyl sulfate-15% polyacrylamide slab 
gels, using the discontinuous Tris-glycine buffer 
system in [ 141. For localization of inhibitory activity, 
gels were sliced (18 I.IL sections) and immediately 
extracted with 0.2 ml water at room temperature. 
The extracts (0.15 ml) were evaporated and assayed 
without removing contaminating dodecyl sulfate since 
the C subunit retains full activity in the presence of 
1 mM dodecyl sulfate [2] . Polyacrylamide (12%) gel 
electrophoresis in the absence of denaturing agents 
was carried out at pH 8.9 as in [ 151. 
Amino acid analyses were performed in a Durrum 
analyzer (Model D 500) as in [ 161 after 24 h, 48 h and 
72 h hydrolysis in 5.7 N HCl at 110°C. Cysteine was 
determined as cysteic acid [ 171 . The NH2 -terminus 
of the molecule was studied by dansylation [ 181. 
Acid-stable, protein-bound phosphate was measured 
as in [lo] on 5-10 nmol protein. 
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Incorporation of [32P]phosphate into PKI under 
the influence of C subunit (19 PM) was studied in 
the presence of 0.6 mM [T-~~P] ATP, 10 mM magne- 
sium acetate, 50 FM PKI, in 30 mM potassium phos- 
phate, 1 mM dithiothreitol, pH 7.0. After 30 min 
incubation at 30°C the proteins were denatured 
(1 min at 1OO’C) and separated on a dodecyl sulfate- 
polyacrylamide gel as described above. Radioactivity 
was immediately estimated by either slicing and 
counting the gels or by autoradiography. Samples were 
never exposed to extremes of pH thus minimizing 
possible losses of bound phosphate. 
3. Results 
Brain PKI was purified by the procedure described 
for the skeletal muscle protein, which includes a heat 
step, batchwise ion-exchanges on DEAE-cellulose and 
phosphocellulose, and affinity chromatography on 
Sepharose 6B to which the catalytic subunit of protein 
kinase is attached [2] . Two slight modifications were 
introduced. First, the affinity step was scaled up by 
the use of a larger column (45 ml) of C-subunit bound 
to Sepharose 6B (3.25 mg enzyme/ml, i.e., 80 PM) 
and buffers contained 1 mM dithiothreitol instead of 
15 mM 2-mercaptoethanol, Second, after the affinity 
step, brain PKI was subjected to a final gel filtration 
through Sephadex G-75 (1.5 X 80 cm column eluted 
at 7.2 ml/h with 0.2 M acetic acid) to eliminate larger 
molecular weight contaminants that emerged in the 
void volume. The material obtained was homogene- 
ous on dodecyl sulfate-polyacrylamide gel electro- 
phoresis, where it migrated with mol. wt 11 OOO- 
12 000, identical to that reported for skeletal muscle 
PKI (fig.1 .A,B). It also exhibits a blocked NH2 - 
terminus, as reported for the muscle protein [2]. 
Confirmation that this single protein band indeed 
represents the inhibitor of protein kinase was obtained 
by assaying individual gel slices. By the same proce- 
dure, a similar inhibitory peptide mol. wt 11 OOO- 
12 000 could be identified in human brain and in 
baboon skeletal muscle (J. G. D. and E. H. F., unpub- 
lished). There is little doubt, therefore, that a mono- 
meric protein of ca. 100 residues exists in various 
tissues and species that displays the properties of PKI. 
PKI from bovine brain and rabbit skeletal muscle 
were kinetically indistinguishable. Both inhibited 
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Fig. 1 .(A,B) Dodecyl sulfate (O.l%)-polyacrylamide (15%) 
slab-gel electrophoresis of 45 pg (A) and 11 wg (B) bovine 
brain PKL RF for protein markers were, respectively, 0.18 
for C subunit (Mr 39 000), 0.28 for carbonic anhydrase 
(M, 29 000), 0.45 for P-lactoglobulin (MI 17 500) and 0.52 
for lysozyme (M, 14 300), relative to dye front. (C) Poly- 
a&amide (12%) disc gel electrophoresis, at pH 8.9, of brain 
PKI (40 pg). (0) origin; (F) dye front. 
markedly the CAMP-dependent protein kinase by 
interacting with its catalytic subunit. This interaction 
occurred as well in the presence or absence of ATP; 
that is, under the conditions for its assay where ATP 
is of course present or during the affinity chromatog- 
raphy step which is carried out in the absence of the 
nucleotide [2]. Both were unable to inhibit the 
cGMP-dependent protein kinase even at a concentra- 
tion in excess of 0.1 mM, i.e., at a level 5 orders of 
magnitude greater than required for a 50% inhibition 
of the CAMP-dependent enzyme (fig.2). On the con- 
trary, addition of either PKI induced a moderate 
increase (up to 1.3-fold) in the rate of phosphate 
incorporation into histones. 
While brain and muscle PKI display certain struc- 
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Fig.2. Effect of PKI on beef lung cGMPdependent protein 
kinase. Assays were performed as in [ 111. In the absence of 
PKI, the enzyme catalyzed the incorporation of 9 pmol 
[s’P]phosphate/min Into mixed histones. (0-e) rabbit 
skeletal muscle PKI; (o- - -0) bovine brain PKI. For com- 
parison, 100% Inhibition of the catalytic subunit of the 
CAMP-dependent protein kinase (16 nM) would occur at a 
PKI concentration > 0.3 PM. 
tural characteristics in common (no sulfur-containing 
amino acid, a single residue of Tyr, Phe and His, a 
high proportion of acidic and hydroxylated amino 
acids, less than 1 residue/m01 protein-bound phos- 
phate) other differences exist in their primary struc- 
ture in that the brain protein contains more Glx and 
Pro residues, perhaps more lysine but less arginine 
and much less bound phosphate (table 1). 
No acid or alkali-stable phosphate could be intro- 
duced in skeletal muscle PKl in the presence of cata- 
lytic subunit and [+y-“P]ATP. The same experiment 
could not be repeated with brain PKl because of scar- 
city of material. Like the skeletal muscle protein, the 
brain inhibitor is heterogeneous on gel electrophoresis 
in the absence of denaturing agents [2] , in that the 
major fraction (RF 0.64, relative to dye front) is 
flanked by two bands of lower intensities (fig.1 C). 
This excludes the possibility that this microhetero- 
geneity results from variable amounts of bound phos- 
phate, (one of the alternatives uggested for the muscle 
inhibitor [2] ) since the brain protein contains only 
0.1 residue/mol. Another explanation would be 
Table 1 
Amino acid and phosphate analysis of protein kinase 
inhibitors (residues/mol) 
Skeletal Bovine 
muscle PKIa brain PKI 
Integer 
Asx 12 13.1 13 
Thrb 8 8.0 8 
Serb 11 11.5 11-12 
Glx 14 17.8 18 
Pro 1 3.5 3-4 
GlY 9 8.9 9 
Ala 15 13.0 13 
ValC 3 3.1 3 
Met 0 0 0 
IleC 5 4.6 4-5 
LeU 7 6.5 6-7 
Tyr 1 0.9 1 
Phe 1 1.1 1 
His 1 0.8 1 
LYS 4 4.7 
Trpd 
5 
0 n.d. n.d. 
Arg 6 3.7. 4 
Cyse 0 0.3 0 
Total 98 100-104 
Phosphatef 0.7 0.1 
a Amino acid composition of skeletal muscle PKI taken from 
[ 21 and given for comparison 
b After extrapolation to zero time of hydrolysis 
’ From the 72 h hydrolysis values 
d n.d., not determined 
e As cysteic acid 
f Acid-stable, protein-bound phosphate (residue/mol) 
partial deamidation or, perhaps more likely, the 
occurrence of ‘isoinhibitors’ which would account for 
the non-integral numbers of residues obtained on 
amino acid analysis (see table 1). 
4. Discussion 
Results described above indicate that bovine brain 
contains a protein kinase inhibitor (or isoinhibitors) 
sharing many properties of the homologous skeletal 
muscle protein, including acidic character, low molec- 
ular weight, similar amino acid composition, ability 
to interact with, and inhibit, the catalytic subunit of 
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CAMP-dependent protein kinases and inability to inhib- 
it the cGMP-dependent protein kinase. 
This latter feature was already described for crude 
preparations of PKI [8,12,19], It also constitutes an 
additional, and perhaps trongest, piece of evidence 
for a difference in the catalytic sites of the two cyclic 
nucleotide-dependent protein kinases [20,21]. This 
would indicate that PKI must possess other structural 
features contributing to its remarkable potency and 
specificity despite the fact that it acts as a competitive 
inhibitor towards protein substrates [2]. 
Although this study does not provide data on the 
cellular and subcellular localization of brain PKI (e.g., 
whether it is of glial or neuronal origin), its isolation 
is of physiological importance, since it is able to inhibit 
not only the cytosolic kinase, but also the neuronal, 
membrane-bound protein kinase [7]. In this respect, 
it would be of interest o try to separate the electro- 
phoretic variants of PKI and check whether or not 
they might interact differently with the various protein 
kinases. 
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